BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10037483)

  • 1. Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.
    Fryer JD; Lukas RJ
    J Neurochem; 1999 Mar; 72(3):1117-24. PubMed ID: 10037483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine.
    Fryer JD; Lukas RJ
    J Pharmacol Exp Ther; 1999 Jan; 288(1):88-92. PubMed ID: 9862757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of steroid exposure on ligand binding and functional activities of diverse nicotinic acetylcholine receptor subtypes.
    Ke L; Lukas RJ
    J Neurochem; 1996 Sep; 67(3):1100-12. PubMed ID: 8752117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone is a non-competitive antagonist at the α4β2 and α3* nicotinic acetylcholine receptors and an agonist at the α7 nicotinic acetylcholine receptor.
    Talka R; Salminen O; Tuominen RK
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):321-8. PubMed ID: 25196810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between tachykinins and diverse, human nicotinic acetylcholine receptor subtypes.
    Lukas RJ; Eisenhour CM
    Neurochem Res; 1996 Oct; 21(10):1245-57. PubMed ID: 8923487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prolonged nicotinic ligand exposure on function of heterologously expressed, human alpha4beta2- and alpha4beta4-nicotinic acetylcholine receptors.
    Gentry CL; Wilkins LH; Lukas RJ
    J Pharmacol Exp Ther; 2003 Jan; 304(1):206-16. PubMed ID: 12490593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional properties of homomeric, human alpha 7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line.
    Zhao L; Kuo YP; George AA; Peng JH; Purandare MS; Schroeder KM; Lukas RJ; Wu J
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1132-41. PubMed ID: 12626641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iptakalim as a human nicotinic acetylcholine receptor antagonist.
    Hu J; Lindenberger K; Hu G; Wang H; Lukas RJ; Wu J
    J Pharmacol Exp Ther; 2006 Feb; 316(2):914-25. PubMed ID: 16223869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relating neuronal nicotinic acetylcholine receptor subtypes defined by subunit composition and channel function.
    Nai Q; McIntosh JM; Margiotta JF
    Mol Pharmacol; 2003 Feb; 63(2):311-24. PubMed ID: 12527802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic nicotinic ligand exposure on functional activity of nicotinic acetylcholine receptors expressed by cells of the PC12 rat pheochromocytoma or the TE671/RD human clonal line.
    Lukas RJ
    J Neurochem; 1991 Apr; 56(4):1134-45. PubMed ID: 2002334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells.
    Eaton JB; Peng JH; Schroeder KM; George AA; Fryer JD; Krishnan C; Buhlman L; Kuo YP; Steinlein O; Lukas RJ
    Mol Pharmacol; 2003 Dec; 64(6):1283-94. PubMed ID: 14645658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "calcium antagonist" TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester] is a potent, non-competitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypes.
    Bencherif M; Eisenhour CM; Prince RJ; Lippiello PM; Lukas RJ
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1418-26. PubMed ID: 8531111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone increases intracellular calcium in SH-SY5Y and SH-EP1-halpha7 cells by activating neuronal nicotinic acetylcholine receptors.
    Pakkanen JS; Nousiainen H; Yli-Kauhaluoma J; Kylänlahti I; Möykkynen T; Korpi ER; Peng JH; Lukas RJ; Ahtee L; Tuominen RK
    J Neurochem; 2005 Sep; 94(5):1329-41. PubMed ID: 16000156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
    Mousavi M; Hellström-Lindahl E
    Neurochem Int; 2009; 54(3-4):237-44. PubMed ID: 19111588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional contribution of the alpha7 subunit to multiple subtypes of nicotinic receptors in embryonic chick sympathetic neurones.
    Yu CR; Role LW
    J Physiol; 1998 Jun; 509 ( Pt 3)(Pt 3):651-65. PubMed ID: 9596789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct pharmacologic properties of neuromuscular blocking agents on human neuronal nicotinic acetylcholine receptors: a possible explanation for the train-of-four fade.
    Jonsson M; Gurley D; Dabrowski M; Larsson O; Johnson EC; Eriksson LI
    Anesthesiology; 2006 Sep; 105(3):521-33. PubMed ID: 16931985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
    Peng JH; Fryer JD; Hurst RS; Schroeder KM; George AA; Morrissy S; Groppi VE; Leonard SS; Lukas RJ
    J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
    Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ
    J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.
    Xiao Y; Meyer EL; Thompson JM; Surin A; Wroblewski J; Kellar KJ
    Mol Pharmacol; 1998 Aug; 54(2):322-33. PubMed ID: 9687574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs.
    Xiao Y; Smith RD; Caruso FS; Kellar KJ
    J Pharmacol Exp Ther; 2001 Oct; 299(1):366-71. PubMed ID: 11561100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.